Financial and treatment access burden associated with atopic dermatitis comorbidities

被引:4
|
作者
Loiselle, Allison R. [1 ]
Thibau, Isabelle J. [1 ]
Johnson, Jessica K. [1 ]
Guadalupe, Michele [1 ]
Begolka, Wendy Smith [1 ]
机构
[1] Natl Eczema Assoc, Novato, CA 94945 USA
关键词
FOOD; EFFICACY; SCALE;
D O I
10.1016/j.anai.2023.10.015
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:243 / 245
页数:3
相关论文
共 50 条
  • [21] Characterization of disease burden and comorbidities in a large, real-world cohort of patients with atopic dermatitis: the CorEvitas Atopic Dermatitis Registry
    Silverberg, Jonathan I.
    Cronin, Angel
    Jones, Eric A.
    Dave, Swapna S.
    McLean, Robert R.
    Greenberg, Jeffrey
    Strober, Bruce
    Bieber, Thomas
    Gooderham, Melinda
    Paller, Amy S.
    Simpson, Eric L.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E84 - E85
  • [22] Efficacy of dupilumab in atopic comorbidities associated with moderate-to-severe adult atopic dermatitis
    Nettis, Eustachio
    Patella, Vincenzo
    Lombardo, Carla
    Detoraki, Aikaterini
    Macchia, Luigi
    Di Leo, Elisabetta
    Carbonara, Monica
    Canonica, Giorgio W.
    Bonzano, Laura
    ALLERGY, 2020, 75 (10) : 2653 - 2661
  • [23] Financial burden of emergency department visits for atopic dermatitis in the United States
    Kwa, Lauren
    Silverberg, Jonathan I.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : 443 - 447
  • [24] Symptomatic burden and treatment needs in adult atopic dermatitis
    Bacci, Elizabeth D.
    Correll, Julia
    Pierce, Evangeline J.
    DeLozier, Amy M.
    Rueda, Maria Jose
    Begolka, Wendy Smith
    Butler, Lisa
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB207 - AB207
  • [25] BIOMARKERS ASSOCIATED WITH THE DEVELOPMENT OF COMORBIDITIES IN PATIENTS WITH ATOPIC DERMATITIS: A SYSTEMATIC REVIEW
    Broderick, Conor
    Ziehfreund, Stefanie
    van Bart, Karin
    Arents, Bernd W. M.
    Eyerich, Kilian
    Weidinger, Stephan
    Rastrick, Joseph
    Zink, Alexander
    Flohr, Carsten
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 53 - 53
  • [26] ATOPIC MARCH AND COMORBIDITIES IN PATIENTS WITH ATOPIC DERMATITIS IN COLOMBIA
    Laignelet, H.
    Ruiz, J.
    Reyes Sanchez, J. M.
    Castano Gamboa, N.
    VALUE IN HEALTH, 2023, 26 (06) : S38 - S38
  • [27] Children With Atopic Dermatitis (AD) Have a High Burden of Atopic Comorbidities: Results From a Large Worldwide Survey
    Silverberg, Jonathan
    Simpson, Eric
    Weidinger, Stephan
    Barbarot, Sebastien
    Brignoli, Lysel
    Mnif, Tarek
    Saba, Grece
    Eckert, Laurent
    Rossi, Ana
    Delevry, Dimittri
    Mahajan, Puneet
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB31 - AB31
  • [28] PROFILE OF COMORBIDITIES ASSOCIATED WITH ATOPIC DERMATITIS AT THE DEPARTMENT OF DERMATOLOGY IN ANTANANARIVO MADAGASCAR
    Rakotonandrasana, Fenohasina
    Manjarimanana, Florine
    Sendrasoa, Fandresena Arilala
    Andriatahina, Princia Herin'Ny Fitiavana
    Desana, Stevy Etienne
    Ralimalala, Nathalie Voahanginirina
    Razafimaharo, Tsiory Iarintsoa
    Ratovonjanahary, Volatantely T.
    Sata, Moril
    Rakotoarisaona, Mendrika Fifaliana
    Razanakoto, Harinjara Naina
    Raharolahy, Onivola
    Andrianarison, Malalaniaina
    Ranaivo, Irina Mamisoa
    Ramarozatovo, Lala Soavina
    Rabenja Rapelanoro, Fahafahantsoa
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 25 - 26
  • [29] Validation of expert opinion in identifying comorbidities associated with atopic dermatitis/eczema
    Ellis, CN
    Drake, LA
    Prendergast, MM
    Abramovits, W
    Boguniewicz, M
    Daniel, CR
    Lebwohl, M
    Stevens, SR
    Whitaker-Worth, DL
    Tong, KB
    PHARMACOECONOMICS, 2003, 21 (12) : 875 - 883
  • [30] Validation of expert opinion in identifying comorbidities associated with atopic dermatitis/eczema
    Charles N. Ellis
    Lynn A. Drake
    Mary M. Prendergast
    William Abramovits
    Mark Boguniewicz
    C. Ralph Daniel
    Mark Lebwohl
    Seth R. Stevens
    Diane L. Whitaker-Worth
    Kuo B. Tong
    PharmacoEconomics, 2003, 21 : 875 - 883